Medicenna Therapeutics Corp.

TSX:MDNA Stock Report

Market Cap: CA$122.7m

Medicenna Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of MDNA?
Owner TypeNumber of SharesOwnership Percentage
Institutions125,0000.16%
Private Companies5,500,0007.04%
VC/PE Firms9,857,86312.6%
Individual Insiders11,812,29215.1%
General Public50,862,74565.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.2%.


Top Shareholders

Top 10 shareholders own 34.92% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.37%
Fahar Merchant
5,762,802CA$9.0m0%no data
7.16%
Rosemina Merchant
5,596,490CA$8.8m0%no data
7.04%
Aries Biologics Inc
5,500,000CA$8.6m0%no data
6.74%
RA Capital Management, L.P.
5,268,788CA$8.3m0%0.07%
5.87%
Aigh Capital Management, LLC
4,589,075CA$7.2m0%2.41%
0.42%
Albert Beraldo
325,000CA$510.2k0%no data
0.16%
ORG Partners LLC
125,000CA$196.2k25%0.02%
0.11%
Orin Hirschman
83,000CA$130.3k0%no data
0.032%
Karen Dawes
25,000CA$39.3k0%no data
0.026%
David Hyman
20,000CA$31.4k0%no data